*/
The scheme allows family law and social work professionals who use AlphaBiolabs’ testing services to nominate local charities for funding, with winners chosen through a bimonthly draw.
The latest draw winner, Victoria Hardy, a legal assistant at Sefton Council, selected Sean’s Place to receive the donation. The charity provides free emotional and practical support to men across Sefton and Liverpool, offering group and one-to-one sessions that focus on confidence building, talking therapies, creative activities and skills development.
Debbie Rogers, Founder and CEO of Sean’s Place, expressed gratitude for the donation, saying it would help the charity continue offering vital support to men experiencing mental health challenges. AlphaBiolabs Director Rachel Davenport praised the organisation’s work, highlighting its important role in promoting early intervention and reducing isolation among men in the local community.
The first Giving Back winner of 2026 will be announced in January, continuing AlphaBiolabs’ commitment to supporting community-focused causes through its unique charitable initiative.
For more information about AlphaBiolabs’ services, including drug, alcohol and DNA testing, call the New Enquiry team on 0333 600 1300, email testing@alphabiolabs.com or request a quote online.
The scheme allows family law and social work professionals who use AlphaBiolabs’ testing services to nominate local charities for funding, with winners chosen through a bimonthly draw.
The latest draw winner, Victoria Hardy, a legal assistant at Sefton Council, selected Sean’s Place to receive the donation. The charity provides free emotional and practical support to men across Sefton and Liverpool, offering group and one-to-one sessions that focus on confidence building, talking therapies, creative activities and skills development.
Debbie Rogers, Founder and CEO of Sean’s Place, expressed gratitude for the donation, saying it would help the charity continue offering vital support to men experiencing mental health challenges. AlphaBiolabs Director Rachel Davenport praised the organisation’s work, highlighting its important role in promoting early intervention and reducing isolation among men in the local community.
The first Giving Back winner of 2026 will be announced in January, continuing AlphaBiolabs’ commitment to supporting community-focused causes through its unique charitable initiative.
For more information about AlphaBiolabs’ services, including drug, alcohol and DNA testing, call the New Enquiry team on 0333 600 1300, email testing@alphabiolabs.com or request a quote online.
Chair of the Bar reflects on 2025
Q&A with criminal barrister Nick Murphy, who moved to New Park Court Chambers on the North Eastern Circuit in search of a better work-life balance
Revolt Cycling in Holborn, London’s first sustainable fitness studio, invites barristers to join the revolution – turning pedal power into clean energy
Rachel Davenport, Co-founder and Director at AlphaBiolabs, reflects on how the company’s Giving Back ethos continues to make a difference to communities across the UK
By Marie Law, Director of Toxicology at AlphaBiolabs
AlphaBiolabs has made a £500 donation to Sean’s Place, a men’s mental health charity based in Sefton, as part of its ongoing Giving Back initiative
Professor Dominic Regan and Seán Jones KC present their best buys for this holiday season
Little has changed since Burns v Burns . Cohabiting couples deserve better than to be left on the blasted heath with the existing witch’s brew for another four decades, argues Christopher Stirling
Six months of court observation at the Old Bailey: APPEAL’s Dr Nisha Waller and Tehreem Sultan report their findings on prosecution practices under joint enterprise
Despite its prevalence, autism spectrum disorder remains poorly understood in the criminal justice system. Does Alex Henry’s joint enterprise conviction expose the need to audit prisons? asks Dr Felicity Gerry KC
With automation now deeply embedded in the Department for Work Pensions, Alexander McColl and Alexa Thompson review what we know, what we don’t and avenues for legal challenge